SP-MHCI-0442-3

Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV

US$507.00

In stock

Description

About Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV

The Respiratory Syncytial Virus (RSV) A (strain S-2) Nucleoprotein Peptide (IEDB: 32357) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Nucleoprotein Peptide, H-KMLKEMGEV-OH (Uniprot: O12395 aa: 137-145) from JPT is produced under strict quality control and quality management.

Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV - Specifications

  • Peptide sequence: H-KMLKEMGEV-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Infection
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV

References:
Read References with JPT’s Antigen Peptides
Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV has been described in:
Immunological characterization of respiratory syncytial virus N protein epitopes recognized by human cytotoxic T lymphocytes., Viral Immunol, 2007 (PMID: 17931110)
Multiplex Identification of Antigen-Specific T Cell Receptors Using a Combination of Immune Assays and Immune Receptor Sequencing., PLoS One, 2015 (PMID: 26509579)
The peptide-binding motif of HLA-DR8 shares important structural features with other type 1 diabetes-associated alleles., Genes Immun, 2011 (PMID: 21654843)

Documentation

Documentation for Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV

Properties

Properties of Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Infection
Layout: Freeze-dried in glass vial
Organism: Respiratory Syncytial Virus (RSV)
Protein Name: Nucleoprotein
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV

Information Values
Sequence: H-KMLKEMGEV-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote